BIOTECanada is served by a volunteer Board of Directors:

Executive Committee

Brad Thompson, President & CEO, Oncolytics Biotech Inc.(Chair)

Luc Mainville, Board Director, Enobia Pharma (Vice-Chair)

Vince Lamanna, President, Novo Nordisk Canada Inc. (Treasurer)

Ron Keefe, President & CEO, Biovectra Inc. (Member at Large)

Peter Brenders, President & CEO - BIOTECanada (Secretary)

Members

Teresa Bitetti, President, Bristol-Myers Squibb Canada Inc.

Brian Bloom, President, Bloom Burton & Co.

Jane Clark, Life Sciences Group Leader, Gowling Lafleur Henderson LLP

Natalie Dakers, CEO, Centre for Drug Research & Development

Michel Fortin, President & CEO, Prevtec Microbia Inc.

Ed Gudaitis, Gilead Sciences Inc., Foster City CA

John Helou, General Manager, Pfizer Canada Inc.

Doug Janzen, President & CEO, Cardiome Pharma Corp.

Kevin Leshuk, General Manager, Celgene Inc.

Mark Lievonen, President, Sanofi Pasteur Limited

David Main, President & CEO, Aquinos Pharmaceuticals

Alexander Marshall, President & Managing Director, Lanxess, Inc.

Gordon McCauley, President & CEO, Allon Therapeutics, Inc.

Greg Penner, President & CEO, NeoVentures Biotechnology Inc.

Andrew Potter, Director & CEO, VIDO, University of Saskatchewan

Thomas Schlader, General Manager, Valeant Canada Inc.

Andrew Sheldon, President & CEO, Medicago Inc.

Jim Wispinski, President & CEO, Dow AgroSciences Canada Inc.